Christophe Duvoux

Summary

Country: France

Publications

  1. doi request reprint Recurrent hepatitis C virus infection post liver transplantation: impact of choice of calcineurin inhibitor
    Christophe Duvoux
    Service d Hepatologie, Hopital Henri Mondor, Creteil, France
    Transpl Int 26:358-72. 2013
  2. pmc A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma
    Andreas A Schnitzbauer
    University Hospital Regensburg, Department of Surgery, Regensburg, Germany
    BMC Cancer 10:190. 2010
  3. doi request reprint Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation
    Daniel Cherqui
    Department of Digestive and Hepatobiliary Surgery and Liver Transplantation, Hôpital Henri Mondor Université Paris 12, 94000, Creteil, France
    Ann Surg 250:738-46. 2009
  4. ncbi request reprint Role of immunosuppression and tumor differentiation in predicting recurrence after liver transplantation for hepatocellular carcinoma: a multicenter study of 412 patients
    Thomas Decaens
    Service d hépatologie et de gastroentérologie, AP HP, Hopital Henri Mondor, Creteil, Unite INSERM 581, France
    World J Gastroenterol 12:7319-25. 2006
  5. doi request reprint Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria
    Christophe Duvoux
    AP HP, Groupe Henri Mondor, Department of Hepatology, Creteil, France
    Gastroenterology 143:986-94.e3; quiz e14-5. 2012
  6. ncbi request reprint Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time
    Thomas Decaens
    Service d hépatologie et de gastroentérologie, Assistance Publique Hopitaux de Paris AP HP, Hopital Henri Mondor, Creteil, France
    Liver Transpl 12:1761-9. 2006
  7. doi request reprint Impact of tumour differentiation to select patients before liver transplantation for hepatocellular carcinoma
    Thomas Decaens
    AP HP, Department of Hepatology, Groupe Henri Mondor Albert Chenevier, Creteil, France
    Liver Int 31:792-801. 2011
  8. doi request reprint Phase II study of sirolimus in treatment-naive patients with advanced hepatocellular carcinoma
    Thomas Decaens
    AP HP, Groupe Hospitalier Henri Mondor, Department of Hepatology, Creteil, France
    Dig Liver Dis 44:610-6. 2012
  9. ncbi request reprint Successful reuse of liver graft 13 years after initial transplantation
    Claude Tayar
    Department of Surgery, Henri Mondor Hospital, University Paris XII, Creteil, France
    Transplantation 82:1547-8. 2006
  10. doi request reprint [Liver transplantation for hepatocellular carcinoma and for patients with pre-existing cancers]
    Monika Hurtova
    Service d Hepato gastro enterologie, Hopital Henri Mondor, AP HP, Université Paris XII Val de Marne, Creteil, France
    Presse Med 38:1272-80. 2009

Collaborators

Detail Information

Publications25

  1. doi request reprint Recurrent hepatitis C virus infection post liver transplantation: impact of choice of calcineurin inhibitor
    Christophe Duvoux
    Service d Hepatologie, Hopital Henri Mondor, Creteil, France
    Transpl Int 26:358-72. 2013
    ....
  2. pmc A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma
    Andreas A Schnitzbauer
    University Hospital Regensburg, Department of Surgery, Regensburg, Germany
    BMC Cancer 10:190. 2010
    ..Therefore, we designed a prospective RCT to determine if the mTOR inhibitor sirolimus can improve hepatocellular carcinoma (HCC)-free patient survival in liver transplant (LT) recipients with a pre-transplant diagnosis of HCC...
  3. doi request reprint Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation
    Daniel Cherqui
    Department of Digestive and Hepatobiliary Surgery and Liver Transplantation, Hôpital Henri Mondor Université Paris 12, 94000, Creteil, France
    Ann Surg 250:738-46. 2009
    ..However, LT is limited by organ availability and tumor progression on the waiting list. Liver resection (LR) may represent an alternative in these patients. The aim of this study is to report the results of LR in transplantable patients...
  4. ncbi request reprint Role of immunosuppression and tumor differentiation in predicting recurrence after liver transplantation for hepatocellular carcinoma: a multicenter study of 412 patients
    Thomas Decaens
    Service d hépatologie et de gastroentérologie, AP HP, Hopital Henri Mondor, Creteil, Unite INSERM 581, France
    World J Gastroenterol 12:7319-25. 2006
    ....
  5. doi request reprint Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria
    Christophe Duvoux
    AP HP, Groupe Henri Mondor, Department of Hepatology, Creteil, France
    Gastroenterology 143:986-94.e3; quiz e14-5. 2012
    ..The aim of this study was to generate an improved prognostic model for predicting recurrence in liver transplant candidates with hepatocellular carcinoma (HCC)...
  6. ncbi request reprint Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time
    Thomas Decaens
    Service d hépatologie et de gastroentérologie, Assistance Publique Hopitaux de Paris AP HP, Hopital Henri Mondor, Creteil, France
    Liver Transpl 12:1761-9. 2006
    ..Their applicability is therefore limited, despite similar survival rates compared to the Milan criteria, when the explanted liver is taken into account...
  7. doi request reprint Impact of tumour differentiation to select patients before liver transplantation for hepatocellular carcinoma
    Thomas Decaens
    AP HP, Department of Hepatology, Groupe Henri Mondor Albert Chenevier, Creteil, France
    Liver Int 31:792-801. 2011
    ..To generate a new score with improved accuracy compared with Milan criteria to select patients...
  8. doi request reprint Phase II study of sirolimus in treatment-naive patients with advanced hepatocellular carcinoma
    Thomas Decaens
    AP HP, Groupe Hospitalier Henri Mondor, Department of Hepatology, Creteil, France
    Dig Liver Dis 44:610-6. 2012
    ..Rapalogs are emerging as promising targeted anticancer drugs. Activation of the PI3K/Akt/mTOR pathway has been observed in 15-50% of hepatocellular carcinomas...
  9. ncbi request reprint Successful reuse of liver graft 13 years after initial transplantation
    Claude Tayar
    Department of Surgery, Henri Mondor Hospital, University Paris XII, Creteil, France
    Transplantation 82:1547-8. 2006
    ..Late reuse has, however, not been reported to date. We report the first case in which a liver graft was successfully reused 13 years after the first transplantation...
  10. doi request reprint [Liver transplantation for hepatocellular carcinoma and for patients with pre-existing cancers]
    Monika Hurtova
    Service d Hepato gastro enterologie, Hopital Henri Mondor, AP HP, Université Paris XII Val de Marne, Creteil, France
    Presse Med 38:1272-80. 2009
    ..They may be considered eligible for a graft after discussion in a multidisciplinary meeting, if the extrahepatic tumor was treated curatively and if their 5-year tumor-related life expectancy is greater than 50-60%...
  11. doi request reprint Pharmacokinetic-pharmacodynamic assessment of tacrolimus in liver-transplant recipients during the early post-transplantation period
    Benoit Blanchet
    Laboratory of Pharmacology and Toxicology, Centre Hospitalier Universitaire Henri Mondor, Creteil, France
    Ther Drug Monit 30:412-8. 2008
    ..Measuring CNA in peripheral blood mononuclear cells 4 hours after tacrolimus intake during the first 3 months after liver transplantation could be a means to improve tacrolimus monitoring and thereby avoid acute graft-rejection episodes...
  12. doi request reprint Non-invasive assessment of liver graft fibrosis by transient elastography after liver transplantation
    Camille Barrault
    Liver Transplantation Unit, Hopital Henri Mondor, 51, Avenue du Marechal de Lattre de Tassigny, 94000 Creteil, France
    Clin Res Hepatol Gastroenterol 37:347-52. 2013
    ..It could be useful in follow-up after liver transplantation (LT). The aim of this study was to assess the diagnostic accuracy of LSM in evaluating liver fibrosis after LT in patients with and without recurrent HCV...
  13. doi request reprint Deficiency in calcineurin activity in liver transplantation candidates with alcoholic cirrhosis or hepatocellular carcinoma
    Benoit Blanchet
    Laboratory of Pharmacology and Toxicology, Centre Hospitalier Universitaire Henri Mondor, Paris XII University, Creteil, France
    Liver Int 29:1152-7. 2009
    ..However, the baseline calcineurin phosphatase activity (CPA) measured before the transplant is unknown. In this study, we determine baseline CPA in liver transplant (LT) candidates and explore some factors that might modify it...
  14. pmc Laparoscopic liver resection for peripheral hepatocellular carcinoma in patients with chronic liver disease: midterm results and perspectives
    Daniel Cherqui
    Department of Digestive Surgery, Liver Transplantation and Hepatobiliary Unit, APHP, Hôpital Henri Mondor Université Paris 12, Creteil, France
    Ann Surg 243:499-506. 2006
    ..Report the midterm results of laparoscopic resection for hepatocellular in chronic liver disease (CLD)...
  15. doi request reprint Transplantation for liver failure in patients with sickle cell disease: challenging but feasible
    Monika Hurtova
    Service d Hepatologie, Université Paris XII Val de Marne France, Creteil, France
    Liver Transpl 17:381-92. 2011
    ..Outcomes may be improved if the neurological complications can be minimized; for example, the administration of a calcineurin inhibitor can be delayed, and the management of HCV infection recurrence can be improved...
  16. pmc Outcomes in adult recipients of right-sided liver grafts in split-liver procedures
    Luca Vigano
    Department of Digestive and Hepatobiliary Surgery, Henri Mondor Hospital University of Paris 12, Creteil, France
    HPB (Oxford) 12:195-203. 2010
    ..The split-liver technique provides a good left lateral graft in children, but its results in adults remain controversial...
  17. ncbi request reprint Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma
    Thomas Decaens
    Service d hépatologie et de gastroentérologie, AP HP, Hopital Henri Mondor, 512 Avenue du Maréchal de Lattre de Tassigny, 94000 Creteil, France
    Liver Transpl 11:767-75. 2005
    ..2%, compared with 54.2% among their matched controls (P = 0.9). In conclusion, with a mean waiting period of 4.2 months and 1 TACE procedure, pre-LT TACE does not influence post-LT overall survival and disease-free survival...
  18. doi request reprint Evaluation of the Architect tacrolimus assay in kidney, liver, and heart transplant recipients
    Christophe Bazin
    Laboratory of Pharmacology, AP HP, CHU H Mondor, Universite Paris XII, 51 Avenue du Marechal de Lattre de Tassigny, Creteil, France
    J Pharm Biomed Anal 53:997-1002. 2010
    ..In conclusion, the tacrolimus CMIA assay is suitable for routine laboratory use and does not suffer from the interferences seen with ACMIA in some patients...
  19. ncbi request reprint Low-grade steatosis and major changes in portal flow as new prognostic factors in steroid-treated alcoholic hepatitis
    Christophe Duvoux
    Service d hépatologie et de gastroentérologie, Unité de Transplantation Hépatique and INSERM U581, Creteil, France
    Hepatology 40:1370-8. 2004
    ..Altered portal flow and steatosis < 20% are new prognostic factors in steroid-treated alcoholic hepatitis and must be taken into account in patient management...
  20. ncbi request reprint [Hepatocellular carcinoma without cirrhosis in a patient with nonalcoholic steatohepatitis]
    Rabia Bencheqroun
    Service d hépatologie et de gastroentérologie, Hopital Henri Mondor, Creteil
    Gastroenterol Clin Biol 28:497-9. 2004
    ..Further epidemiological studies are needed to evaluate the incidence of this association...
  21. ncbi request reprint Activated protein C resistance acquired through liver transplantation and associated with recurrent venous thrombosis
    Catherine Leroy-Matheron
    Unité d Hémostase et de Thrombose, Centre Hospitalier Universitaire Henri Mondor, AP HP, Creteil, France
    J Hepatol 38:866-9. 2003
    ....
  22. ncbi request reprint Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study
    Christophe Duvoux
    Service d hépatologie et de gastroentérologie, AP HP, Hopital Henri Mondor, Creteil, France
    Hepatology 36:374-80. 2002
    ..5 mg/h NA) that did not recur after a dose reduction. In conclusion, NA combined with albumin and furosemide appears effective and safe for the treatment of type 1 HRS...
  23. ncbi request reprint Hepatitis C virus (HCV)-related cryoglobulinemia after liver transplantation for HCV cirrhosis
    Christophe Duvoux
    Service d hépatologie et de gastroentérologie, Hopital Henri Mondor, Universite Paris XII, 51, Avenue du Marechal de Lattre de Tassigny, 94010 Creteil, France
    Transpl Int 15:3-9. 2002
    ..Cryoglobulinemia did not seem to be associated with more severe graft damage. Cryoglobulinemia-associated morbidity must be taken into account in the management of post-transplant HCV infection...
  24. ncbi request reprint Infliximab therapy for rheumatic diseases in patients with chronic hepatitis B or C
    Owonayo Oniankitan
    Department of Rheumatology, Henri Mondor Teaching Hospital, AP HP, Creteil, France
    J Rheumatol 31:107-9. 2004
    ..To describe the safety of tumor necrosis factor-a blockade in 2 patients with inflammatory rheumatic disease with chronic hepatitis B and C...
  25. ncbi request reprint Liver transplantation for hepatopulmonary syndrome: a ten-year experience in Paris, France
    Camille Taillé
    Service de Pneumologie et de Reéanimation Respiratoire et INSERM U408, Service d Hepatologie, Service de Chirurgie Digestive, Hopital Beaujon, Clichy, France
    Transplantation 75:1482-9; discussion 1446-7. 2003
    ..Although the possibility of reversing hepatopulmonary syndrome (HPS) after liver transplantation is now well established, the proportion of patients in whom reversibility is observed and the time to resolution of HPS remain uncertain...